EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Copper-Induced Enhancement of Glioblastoma Tumorigenicity via Cytochrome C Oxidase

Claudia R Oliva, Md Yousuf Ali iD, Susanne Flor iD, Corinne E Griguer

Antioxidants · 24.01.2025 · 14 (2) · 142

DOI: 10.3390/antiox14020142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 24.01.2025. Verfasst von Claudia R Oliva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Free Radical & Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa, IA 52242, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Copper is an essential trace element, yet chronic copper exposure can lead to toxicity in humans, and high levels of copper have been found in the blood or tumors of patients with various forms of cancer and may affect cancer severity and response to treatment. Copper is required for the activation of cytochrome c oxidase (CcO), the mitochondrial complex that facilitates oxidative phosphorylation (OXPHOS)-mediated ATP production. We recently reported that the increased activation of CcO underlies the acquisition of treatment resistance in glioblastoma (GBM) cells. However, the potential role of copper in GBM progression or treatment resistance has not been investigated. Here, we present evidence that exposure to 20 µM copper, the maximum allowable limit for public water supplies set by the U.S. Environmental Protection Agency, promotes GBM tumor growth and reduces overall survival in vivo and increases GBM cell resistance to radiation and chemotherapy in vitro. In vitro exposure to 20 µM copper substantially increased the activity of CcO, elevated the rate and level of ATP production, and triggered a metabolic shift to an OXPHOS phenotype in GBM cells. Furthermore, copper exposure led to a substantial increase in the accumulation of glutathione and glutathione precursors in these cells. These findings establish copper as a tumor promoter in GBM and suggest that copper mediates these effects through the upregulation of CcO activity, which enhances OXPHOS metabolism and glutathione production.

Schlagwörter

Stichwörter der Autor:innen

coppercytochrome c oxidaseglioblastomaoxphos

Autor:innen und Institutionen

  • Free Radical & Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa, IA 52242, USA.
  • Mass General Hospital Center for Cancer Research, Harvard Medical School, Boston, MA 02129, USA.

ORCID-Profile: Md Yousuf Ali, Susanne Flor

Förderung

  • NIEHS NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center
  • the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)

Zitieren

APA

Oliva, C. R., Ali, M. Y., Flor, S., & Griguer, C. E. (2025). Copper-Induced Enhancement of Glioblastoma Tumorigenicity via Cytochrome C Oxidase. Antioxidants, 14(2), 142. https://doi.org/10.3390/antiox14020142

Vancouver

Oliva CR, Ali MY, Flor S, Griguer CE. Copper-Induced Enhancement of Glioblastoma Tumorigenicity via Cytochrome C Oxidase. Antioxidants. 2025;14(2):142. doi:10.3390/antiox14020142

BibTeX
@article{Oliva2025,
  author = {Oliva, Claudia R and Ali, Md Yousuf and Flor, Susanne and Griguer, Corinne E},
  title = {Copper-Induced Enhancement of Glioblastoma Tumorigenicity via Cytochrome C Oxidase},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {142},
  doi = {10.3390/antiox14020142}
}
Kostenlos starten →